- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Health
V-Bio Ventures finalises Fund 2
Venture capital firm V-Bio Ventures has reached the final close of its second fund, with Vanden Avenue Commodities among the limited partners.
Mar 31, 2022SoftBank spearheads $100m Neuron23 round
The neurological disease treatment developer took its funding to over $213m, completing a series C round led by SoftBank Vision Fund 2.
Mar 31, 2022LetsGetChecked to buy Veritas Genetics
LetsGetChecked is moving into genomics with the acquisition of the genetic testing technology provider, allowing Lilly Ventures Asia and Jiangsu Simcere to exit.
Mar 31, 2022Exits: March 31, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Mar 31, 2022Deals: March 31, 2022
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Mar 31, 2022V-Bio Ventures completes $120m fundraising
VIB-backed venture capital firm V-Bio Ventures has reached the final close of its second fund and hired Shelley Margetson as managing partner.
Mar 31, 2022Daily Deal Round Up: March 30, 2022
Alibaba helped AR glasses provider Nreal take its funding to $200m in the past year while SGE led a $60m series D round for online coder recruitment service HackerRank.
Mar 30, 2022Daily Deal Round Up: March 29, 2022
DigitalBridge Ventures led wireless adoption software developer Celona's $60m series C round while Papaya is paying up to $200m for Rakuten-backed payment platform developer Azimo.
Mar 29, 2022Exits: March 29, 2022
A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.
Mar 29, 2022Deals: March 29, 2022
The Global University Venturing deal net rounds up the smaller investments from across the university innovation ecosystem.
Mar 29, 2022AN2 Therapeutics prices $69m IPO
The Brii Biosciences-backed lung disease treatment developer priced an upsized offering in the middle of its range.
Mar 29, 2022Celsius heats up with $83m
Amgen Ventures and existing backers GV, Heritage Provider Network and Alexandria Venture Investments helped the cancer and IBD drug developer secure fresh funding.
Mar 28, 2022Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation


